Company / Capital Expenditures
MUSTANG BIO, INC. Capital Expenditures History
FY2018-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$6.9M
FY2019
5-year range
$424.0K / $6.9M
FY2018-FY2019
Trend
+1520.3%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$7M in FY2019.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, capital expenditures increased 1520.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.37 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $6.9M | +1520.3% |
| FY2018 | $424.0K | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026